GGrantIndex
Sort

15,440 grants matching organoids

Epithelial interactions with indigenous and pathogenic microbes

$478,032
Vincent B Young · University Of Michigan At Ann Arbor · U19 · FY2017 · AI

Developing new therapeutic strategies for distinct Ras-driven cancers

$478,002
Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2025 · CA

Metaplastic Tuft Cells in Pancreatic Cancer

$477,977
Howard C Crawford · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling

$477,871
Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2019 · CA

Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1

$477,848
Teresa Davoli · New York University School Of Medicine · R37 · FY2025 · CA

Establishing the Repertoire of Actionable Alterations in Appendiceal Adenocarcinoma

$477,793
Lance David Miller · Wake Forest University Health Sciences · R01 · FY2025 · CA

Project 2 - Protein Ubiquitylation in Esophageal Cancer

$477,730
J. Alan Diehl · Columbia University Health Sciences · P01 · FY2021 · CA

3D dynamic contrast optical coherence microscopy for organoid studies

$477,591
Shu-Wei Huang · University Of Colorado · R01 · FY2025 · EB

Networks for functional regulation of pancreatic acinar-ductal metaplasia and epithelial plasticity

$477,531
Anil K Rustgi · Columbia University Health Sciences · R01 · FY2023 · DK

Tumor repressive role of Ets2 in the intestine

$477,500
Robert G Oshima · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · DK

Core I: iPSC Core

$477,445
Jerome S. Mertens · University Of California, San Diego · P30 · FY2024 · AG

Diet induced modifications of microbiota metabolites in colon tumorigenesis

$477,180
Robert Stephen Chapkin · Texas A&M Agrilife Research · R01 · FY2017 · CA

qHTS of Patient Derived HCC Models to Identify Novel Probes/Therapeutic Agents

$477,136
Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

Molecular Cytology

$477,125
Katia Ognianova Manova · Sloan-Kettering Inst Can Research · P30 · FY2022 · CA

Molecular Cytology

$477,125
Katia Ognianova Manova · Sloan-Kettering Inst Can Research · P30 · FY2023 · CA

Molecular Cytology

$477,125
Katia Ognianova Manova · Sloan-Kettering Inst Can Research · P30 · FY2021 · CA

Molecular Cytology

$477,125
Katia Ognianova Manova · Sloan-Kettering Inst Can Research · P30 · FY2020 · CA

Gene Regulation Underlying Photoreceptor Neurodegeneration

$477,109
Katherine Jean Wert · Ut Southwestern Medical Center · R01 · FY2025 · EY

Project 2 - Protein Ubiquitylation in Esophageal Cancer

$477,079
J. Alan Diehl · Columbia University Health Sciences · P01 · FY2023 · CA

Investigating mechanisms of tumor plasticity in human bladder cancer

$476,991
Michael M. Shen · Columbia University Health Sciences · R01 · FY2025 · CA

Investigating mechanisms of tumor plasticity in human bladder cancer

$476,991
Michael M. Shen · Columbia University Health Sciences · R01 · FY2024 · CA

Estrogen Receptor and NFkB Crosstalk in Breast Cancer

$476,982
Jonathan L. Coloff · University Of Illinois At Chicago · R01 · FY2025 · CA

Estrogen Receptor and NFkB Crosstalk in Breast Cancer

$476,979
Jonna Frasor · University Of Illinois At Chicago · R01 · FY2022 · CA

Unraveling the Aggregation of TDP43 Fragments Associated with ALS and FTD: Insights into Protein Quality Control Mechanisms and Cellular Vulnerability

$476,973
Christopher Scott Brower · Texas Woman'S University · R15 · FY2025 · NS

ERβ repurposes EZH2 to suppress oncogenic NFκB signaling in TNBC

$476,895
John R Hawse · Mayo Clinic Rochester · R01 · FY2021 · CA